# Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease

> **NCT03250741** · PHASE2 · COMPLETED · sponsor: **I.R.C.C.S. Fondazione Santa Lucia** · enrollment: 94 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Rotigotine transdermal patch
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03250741
- **Lead sponsor:** I.R.C.C.S. Fondazione Santa Lucia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2018-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03250741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03250741, "Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03250741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*